Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 13 recruiting now full pipeline

Acute Pain: full-pipeline trial registry

13 of 51 indexed Acute Pain trials are currently recruiting.

Corpus placement: #274 of 28,707 conditions by registered trial count.

51 US clinical trials · 13 currently recruiting · #274 of 28,707 conditions by registered trial count

Acute Pain: 51 US clinical trials tracked, 13 recruiting.

Acute Pain is the subject of 51 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 17 in Phase 1-2 (earlier-stage). The most active sponsor is Montefiore Medical Center, running 3 of these trials.

Enrollment posture brief

Registry condition acute-pain

OPEN 13 | RECR 25% | LATE 13 | EARLY 17 | RANK #274 | SPON 3

Nearest open-share peer: Tobacco Use Disorder (25% recruiting · 75 trials)

Long COVID62.7%Peripheral Artery Disease54.9%Idiopathic Pulmonary Fibrosi42.3%Acute Pain (this)25%Congestive Heart Failure15.4%
Open-enrollment share among volume-matched conditions near Acute Pain

Acute Pain lists 13 open slots (25% of 51 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Pain is recruiting below its size-band peers.

    13 of 51 indexed trials (25.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Acute Pain trials is spread across many organizations.

    Montefiore Medical Center accounts for 3 of 51 trials (5.9%). 42 distinct sponsors appear on at least one study for this condition label.

  3. Typical Acute Pain enrolment sits around 110 participants.

    Median target enrolment is 110 among the 51 trials that report a genuine target (sentinel values excluded). 22 of those (43.1%) plan for fewer than 100 participants.

  4. Acute Pain research is mostly interventional.

    42 interventional and 9 observational studies make up this index (82.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 15Phase 212Phase 310Phase 43

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 12
Phase 3 10
Phase 4 3

Named interventions

Most-linked intervention names on Acute Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
9 trials
MR-107A-02 Drug
2 trials
Placebo (matched to HB/APAP) Drug
2 trials
Placebo (matched to VX-548) Drug
2 trials
HB/APAP Drug
2 trials
VX-548 Drug
2 trials
Pharmacogenetic testing Other
2 trials
Pain Psychoeducation Behavioral
2 trials

US sites by state

Facility locations filed on Acute Pain trials. A trial with sites in several states counts in each.

Texas 10 trials
California 10 trials
Utah 9 trials
Maryland 8 trials
Florida 6 trials
Arizona 6 trials
North Carolina 5 trials
Ohio 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Pain page

51 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Pain condition card totals 51 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.